President Donald Trump has doubled down on his protectionist trade strategy, raising worldwide tariffs to 15% just hours after the Supreme Court ruled his previous actions illegal. The President’s decision to increase the rate from 10% to 15% is seen by many as a direct challenge to the judiciary’s authority. By citing the Trade Act of 1974, Trump claims he has found a “legally permissible” path to continue his mission of shielding American industry from foreign competition.
The rhetoric coming from the White House has been exceptionally sharp. Trump didn’t hold back in his criticism of the 6-3 ruling, calling the opinion “poorly written” and “anti-American.” He specifically targeted the “Rinos” and “radical-left Democrats” whom he believes have influenced the court. This public breakdown in relations between the executive and judicial branches adds a layer of political volatility to an already strained economic environment.
In Europe, the response has been a mix of legal praise and economic dread. While leaders like Emmanuel Macron celebrated the “rule of law” displayed by the U.S. court system, they are now bracing for the 15% hike. German Chancellor Friedrich Merz has voiced concerns that the progress made by the court’s ruling has been instantly erased by Trump’s latest decree. Merz is advocating for a coordinated European front to convince the U.S. government that unilateral tariffs are a “poison” to mutual prosperity.
The financial burden of this policy shift is expected to fall largely on the American public. Previous studies on the initial 10% tariffs showed that 90% of the $130 billion collected was paid by U.S. consumers and firms. Despite the President’s claims that foreign nations are being “punished,” the domestic clamor for refunds is growing. However, the administration has made it clear that no reimbursements will be issued without a protracted fight in the courts.
As the new 15% tariffs are set to go into effect at 12:01 am on Tuesday, February 24, the global trade community is on high alert. While Canada and Mexico are shielded by USMCA compliance, and certain medical goods are exempt, the rest of the world faces a steep 150-day trial. This period will likely be defined by further legal challenges as opponents of the tariff attempt to close the Section 122 loophole Trump is currently exploiting.